First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 2
- Registration Number
- NCT06239636
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes
Phase 1
Completed
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Drug: Gamma-Aminobutyric Acid (GABA)
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 35
- Registration Number
- NCT03635437
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
Brown Adipose Tissue in Type 1 Diabetes
Not Applicable
Completed
- Conditions
- Type1diabetes
- Interventions
- Radiation: Positron emission tomography with tracer 18F-deoxy glucose
- First Posted Date
- 2016-12-07
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 11
- Registration Number
- NCT02984514
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
[11C]5-Hydroxy-tryptophan PET for Assessment of Islet Mass in Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Type2 Diabetes
- Interventions
- Radiation: Positron emission tomography with the tracer [11C]5-hydroxy-tryptophan
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 39
- Registration Number
- NCT02967354
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
Phase 2
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2020-11-05
- Lead Sponsor
- Per-Ola Carlsson
- Target Recruit Count
- 18
- Registration Number
- NCT02617654
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
© Copyright 2025. All Rights Reserved by MedPath